A 54-year-old woman (Fitzpatrick III) with superficial fat deflation and poor skin elasticity had shown limited improvement after several high-volume BDDE-HA treatments.
The treatment proved more effective, with excellent biointegration and a high safety profile in Hashimoto patients, thanks to the absence of inflammatory responses. By stimulating fibroblasts and collagen I/III production, Neauvia Stimulate promoted true bioregeneration, even in delicate, autoimmune-compromised skin.
Switching to Neauvia Stimulate (PEGHA 26 mg/ml with CaHA) resulted in clear redefinition of fat compartments, improved skin quality, and long-lasting effects.
Lorem ipsum dolor sit amet consectetur. Elementum feugiat risus morbi et nulla aliquam tortor adipiscing. Erat quam neque morbi ornare leo duis viverra massa est.